May 15, 2025

The Centers for Medicare and Medicaid Services (CMS) announced the suspension of eight Merit-based Incentive Payment System (MIPS) Improvement Activities (IAs) for the 2025 performance year. They are:

  • IA_AHE_5: MIPS Eligible Clinician Leadership in Clinical Trials or CBPR.
  • IA_AHE_8: Create and Implement an Anti-Racism Plan.
  • IA_AHE_9: Implement Food Insecurity and Nutrition Risk Identification and Treatment Protocols.
  • IA_AHE_11: Create and Implement a Plan to Improve Care for Lesbian, Gay, Bisexual, Transgender, and Queer Patients.
  • IA_AHE_12: Practice Improvements that Engage Community Resources to Address Drivers of Health.
  • IA_PM_6: Use of Toolsets or Other Resources to Close Health and Health Care Inequities Across Communities.
  • IA_ERP_3: COVID-19 Clinical Data Reporting with or without Clinical Trial.
  • IA_PM_26: Vaccine Achievement for Practice Staff: COVID-19, Influenza, and Hepatitis B.

Although CMS advises clinicians to select alternative improvement activities when reporting to MIPS in 2025, practices that already completed or were in the process of completing these activities prior to May 6, can still receive credit for the activity.

CMS said it will post updated improvement activity specifications to the QPP Resource Library in the coming weeks.

If you have questions about 2025 MIPS participation or the suspended IAs, contact Zach Smith, American College of Radiology® Senior Quality Programs Specialist.

Related ACR News

  • CMS Releases NCCI Quarterly Edit Files

    The Centers for Medicare and Medicaid Services released the quarterly National Correct Coding Initiative Procedure-to-Procedure edits, effective Oct. 1.

    Read more
  • HHS Officials Meet with Health Insurers on Prior Authorization

    Robert F. Kennedy, Jr., secretary of HHS, and Mehmet Oz, MD, MBA, administrator of CMS, hosted a roundtable discussion with health insurance industry leaders

    Read more
  • Seven States Enact Breast Health Legislation

    The 2025 state legislative sessions have seen an increased amount of breast health legislation and expanding access to screenings.

    Read more